Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.
Pu Xia(Integrated Chinese Medicine (China)), George L. King(Joslin Diabetes Center), D J Park(Joslin Diabetes Center), William Newsome(Joslin Diabetes Center), Lloyd Paul Aiello(Joslin Diabetes Center), Hideki Ishii(Gunma University), Zhen Jiang(Fujian Medical University), Hitoshi Takagi(Joslin Diabetes Center), M.R. Jirousek(Eli Lilly (United States)), G.S. Robinson
Cited by 570
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979